Navigation Links
Stereotaxis Showcases Advancements for Remote Magnetic Ablations
Date:1/14/2009

ST. LOUIS, Jan. 14 /PRNewswire-FirstCall/ -- At the Boston Atrial Fibrillation Symposium, Stereotaxis, Inc. (Nasdaq: STXS) will showcase three advances in remote magnetic ablation that it believes will enhance the efficiency, performance and versatility of its Niobe(R) Magnetic Navigation System. In booth #917, Stereotaxis will exhibit its new software platform, Navigant 3.0, with the QuikCAS(TM) Cardiodrive(R) System for enhanced remote catheter control and improved EP lab workflow, and its partnered magnetic irrigated catheter, which is now available in Europe.

"Together these three products represent a significant advancement in remote cardiovascular procedures," said Michael P. Kaminski, Stereotaxis President and CEO.

-- The QuikCAS Cardiodrive System remotely advances and retracts the catheter in the patient's heart while the Niobe magnets precisely steer the catheter's distal tip. The QuikCAS advancements provide the clinician with greater responsiveness for enhanced performance, a more ergonomic design and faster set-up for improved workflow.

-- Stereotaxis' partnered magnetic irrigated catheter, now available in Europe, is widely recognized as the gold standard for complex ablations such as ventricular tachycardia and complex left atrial arrhythmias. European clinicians have treated more than 600 patients with the magnetic irrigated catheter, with extremely positive results. Stereotaxis has prepared a monograph of these results and will be highlighting the data at the Symposium.

-- Navigant 3.0 is Stereotaxis' new software platform for its Niobe Magnetic Navigation System. It provides users with many enhanced features and new capabilities that simplify and accelerate its use, including automated registration of the 3D mapping system and calibration of the Cardiodrive System; faster and more accurate automation with re-targeting to compensate for patient movement; and broader integration with other EP Lab systems. Particularly when used in combination with Odyssey(TM), Stereotaxis believes that Navigant 3.0 will significantly advance EP lab productivity and procedural workflow efficiency.

In addition, clinicians can test drive the full Odyssey information management solution including its new Odyssey Workstation 3.0 software and the Odyssey Cinema(TM) data management system for remote viewing and recording of live interventional cases. From an Odyssey Workstation in booth 917, clinicians will be able to control a catheter in a beating heart phantom located 1,200 miles away in the company's St. Louis headquarters. Alongside the Odyssey Workstation, clinicians can experience Odyssey Cinema for remote viewing, recording, playback and annotation of synchronized lab information showing the full context of the procedure. Odyssey Cinema can then broadcast their case through an Odyssey Connect network link to another hospital on the global Odyssey network, or during this conference to a partner's booth across the exhibit hall, allowing clinicians to experience the clear advantages of the Odyssey network for clinical collaboration, remote consultation, and training.

"Some 18,000 procedures performed with the Niobe Magnetic Navigation System have established its reputation for clinical safety, utility, and efficacy," said Mr. Kaminski. "We continue to innovate and deliver the most powerful combination of products available to the electrophysiologist, and are positioned to revolutionize the interventional lab with automation, information management, and networking."

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance for the Company's products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that the Company will recognize revenue related to its purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of the Company's control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays.


'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Stereotaxis Appoints Senior Vice President, North America
2. Stereotaxis to Present at the Seventh Annual JMP Securities Research Conference
3. Stereotaxis Market Leadership Highlighted at Heart Rhythm 2008
4. Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network
5. Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
6. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
7. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
8. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
9. Annual List of Best Doctors in Dallas Showcases Texas Institute for Surgery Physicians
10. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
11. Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences , ... life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer ... “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to ...
(Date:10/9/2017)... ... 2017 , ... The Giving Tree Wellness Center announces the ... of consumers who are incorporating medical marijuana into their wellness and health regimens. ... operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach Mazor ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech Venture Network ... at their fourth annual Conference where founders, investors, innovative practitioners and collaborators are ... pitch competition showcasing early stage digital health and med tech companies. , This ...
Breaking Biology Technology:
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:5/6/2017)... 2017 RAM Group , Singaporean ... breakthrough in biometric authentication based on a ... to perform biometric authentication. These new sensors are based ... by Ram Group and its partners. This sensor will ... chains and security. Ram Group is a next ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert ... a media edge server, the M820, which features the company,s hybrid ... software provided by Tera Probe, Inc., will be showcased during the ... the NAB show at the Las Vegas ... ...
Breaking Biology News(10 mins):